MTCO1P47

Across TCGA pan-cancer cohorts, MTCO1P47 RNA is linked to patient survival in 12 of 34 cancer types, making it the most broadly survival-associated MTCO1P47 data layer.

The strongest signal is observed in cholangiocarcinoma (CHOL), where higher MTCO1P47 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MTCO1P47 expression acts as an unfavorable survival marker, although some lineages such as BRCA and UCS show a favorable association.

CHOL, UCEC, and HNSC are the cancer types where MTCO1P47 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
CHOL	OS	Tertile	All	0.024	0.728	<.001	108	view →
UCEC	DFS	Tertile	III,IV	0.613	0.829	.001	78	view →
HNSC	DFS	Tertile	II,III,IV	0.170	0.576	<.001	63	view →
KIRC	OS	Tertile	II,III,IV	0.301	0.553	.003	60	view →
MESO	OS	Tertile	All	0.289	0.557	.014	45	view →
ESCA	DFS	Median	IV	0.205	0.634	.006	45	view →
BRCA	DFS	Tertile	III,IV	1.000	0.865	.025	30	view →
UCS	DFS	Tertile	III,IV	0.707	0.160	.008	24	view →
LGG	DFS	Quartile	All	0.547	0.804	<.001	23	view →
LUSC	OS	Tertile	II,III,IV	0.865	0.722	.020	18	view →
UVM	DFS	Tertile	III,IV	0.071	0.636	<.001	9	view →
STAD	OS	Quartile	II,III,IV	0.318	0.554	.032	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 12 lineages.

MTCO1P47–CHOL (OS)

Open the CHOL breakdown →